Mach5 Therapeutics, Inc.
Biotechnology company · Atlanta, Georgia, United States
Mach5 Therapeutics, Inc. is a biotechnology company headquartered in Atlanta, Georgia, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2024.
Mach5 Therapeutics at a glance
What does Mach5 Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $19.2 million sold (2024).
Frequently asked questions about Mach5 Therapeutics
Where is Mach5 Therapeutics headquartered?
Mach5 Therapeutics, Inc. is headquartered in Atlanta, Georgia, United States.
What does Mach5 Therapeutics do?
Mach5 Therapeutics, Inc. is a biotechnology company.
When was Mach5 Therapeutics founded?
The earliest incorporation on record for Mach5 Therapeutics, Inc. is in 2023, according to public company registers.
Similar companies
- NeurOp, Inc.Atlanta, Georgia, United States
- Axion BioSystems, Inc.Atlanta, Georgia, United States
- Micron Biomedical, Inc.Atlanta, Georgia, United States
- KDH Research & Communication, Inc.Atlanta, Georgia, United States
- Andson Biotech Inc.Atlanta, Georgia, United States
- Microbplex, Inc.Atlanta, Georgia, United States
- BrainTrust BIO Inc.Atlanta, Georgia, United States
- Kinemo, Inc.Atlanta, Georgia, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences